GAIN THERAPEUTICS, INC Capitalized Computer Software, Gross
GAIN THERAPEUTICS, INC (GANX) had Capitalized Computer Software, Gross of $296.17 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Capitalized Cost, Software to be Sold, Leased, or Marketed, after Accumulated Amortization
us-gaap:CapitalizedComputerSoftwareGross · last filed 2026-08-11
- 2026-06-30: Capitalized Computer Software, Gross $296.17K.
- 2026-03-31: Capitalized Computer Software, Gross $300.30K.
- 2025-12-31: Capitalized Computer Software, Gross $302.12K.
- 2025-09-30: Capitalized Computer Software, Gross $300.85K.
| Period end | Capitalized Computer Software, Gross |
|---|---|
| 2026-06-30 | $296.17K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $300.30K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $302.12K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $300.85K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $302.20K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $271.24K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $264.06K 10-K · filed 2026-03-26 |
| 2023-12-31 | $284.64K 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |